Loading ...
96052686.Predictive factorsinfluencingthe therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients
Similar articles Select item 960526818.Predictive factorsinfluencingthe therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients
Kovac et al . ... fentanyl administrationto preventhemodynamic responses to tracheal intubation in healthy patients
keywords = " AIDS , Cerebrospinal fluid , Highly active antiretroviral therapy , HIV , HIV-1 RNA " , author = " Andrea Antinori and Giancola , { Maria Letizia } and Susanna Grisetti and Fabio Soldani and Lucia Alba and Giuseppina Liuzzi and Alessandra Amendola and Maria Capobianchi and Valerio Tozzi and Perno , { Carlo Federico } " , doi = " 10.1097/00002030 - 200209270 - 00003influencingvirological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients AU - Capobianchi
Overexpressed E4BP4 ( NFIL3 ) , an important human transcription factorledto the downregulation of the autoimmune responses in SLE patients
the T lymphocytes within the tumor mass to proliferate and become more activeto causethe T lymphocytes within the tumor mass to proliferate and become more active
them to become prone to oral , skin , genital infections and in worst cases , a fatal whole - body infectioncausesthem to become prone to oral , skin , genital infections and in worst cases , a fatal whole - body infection
in a higher mortality rate Hypotension < 90 mmresultedin a higher mortality rate Hypotension < 90 mm
to altered gene expression programmes and a similar muscle degeneration phenotypecould leadto altered gene expression programmes and a similar muscle degeneration phenotype
recurrencesto preventrecurrences
in percent in any actionsdo yet resultin percent in any actions
regression of tumors that were directly targeted with ISV , as well as untreated tumorspromptingregression of tumors that were directly targeted with ISV , as well as untreated tumors
and develop novel immunotherapiesto discoverand develop novel immunotherapies